IL175089A - Polypeptides encoded by the mutant oligoadenylated gene - Google Patents
Polypeptides encoded by the mutant oligoadenylated geneInfo
- Publication number
- IL175089A IL175089A IL175089A IL17508906A IL175089A IL 175089 A IL175089 A IL 175089A IL 175089 A IL175089 A IL 175089A IL 17508906 A IL17508906 A IL 17508906A IL 175089 A IL175089 A IL 175089A
- Authority
- IL
- Israel
- Prior art keywords
- seq
- rna
- polypeptide
- oasl
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51388803P | 2003-10-23 | 2003-10-23 | |
| US54237304P | 2004-02-06 | 2004-02-06 | |
| US55475804P | 2004-03-19 | 2004-03-19 | |
| US56052404P | 2004-04-08 | 2004-04-08 | |
| US57832304P | 2004-06-09 | 2004-06-09 | |
| US58350304P | 2004-06-28 | 2004-06-28 | |
| US60524304P | 2004-08-26 | 2004-08-26 | |
| PCT/US2004/035284 WO2005040428A2 (en) | 2003-10-23 | 2004-10-22 | Detection of mutations in a gene associated with resistance to viral infection, oas1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL175089A0 IL175089A0 (en) | 2006-08-20 |
| IL175089A true IL175089A (en) | 2013-10-31 |
Family
ID=42331514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL175089A IL175089A (en) | 2003-10-23 | 2006-04-23 | Polypeptides encoded by the mutant oligoadenylated gene |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20050191649A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2011142913A (cg-RX-API-DMAC7.html) |
| IL (1) | IL175089A (cg-RX-API-DMAC7.html) |
| NZ (3) | NZ591879A (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0415771A (pt) | 2003-10-23 | 2006-12-26 | Illumigen Biosciences Inc | detecção de mutações em um gene associado à resistência a infecção viral, oas1 |
| UA95446C2 (ru) | 2005-05-04 | 2011-08-10 | Іллюміджен Байосайєнсіз, Інк. | Мутаци в генах oas1 |
| US11439689B2 (en) * | 2016-11-14 | 2022-09-13 | Kaohsiung Medical University | Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863873A (en) * | 1980-01-14 | 1989-09-05 | Esa, Inc. | Method for biological testing and/or developing pharmaceuticals for treatment of disorders |
| US5266459A (en) * | 1992-02-24 | 1993-11-30 | The Scripps Research Institute | Gaucher's disease: detection of a new mutation in intron 2 of the glucocerebrosidase gene |
| US5597709A (en) * | 1994-01-27 | 1997-01-28 | Human Genome Sciences, Inc. | Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| US5840565A (en) * | 1995-08-22 | 1998-11-24 | The Regents Of The University Of California | Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
| AU3367799A (en) * | 1998-03-30 | 1999-10-18 | Esa Inc. | Methodology for predicting and/or diagnosing disease |
| US20010034023A1 (en) * | 1999-04-26 | 2001-10-25 | Stanton Vincent P. | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
| US20030165921A1 (en) * | 2000-02-03 | 2003-09-04 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| AU2001245619A1 (en) * | 2000-03-09 | 2001-09-17 | Chiron Corporation | Human genes and gene expression products |
| AU2002341207A1 (en) * | 2001-05-08 | 2002-11-18 | Switch Biotech Ag | Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing |
| US6818420B2 (en) * | 2002-02-27 | 2004-11-16 | Biosource International, Inc. | Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same |
| US7354908B2 (en) * | 2002-04-30 | 2008-04-08 | University Of South Florida | Materials and methods for prevention and treatment of RNA viral diseases |
| WO2004044124A2 (en) * | 2002-05-17 | 2004-05-27 | Baylor College Of Medicine | Identification of oligoadenylate synthetase-like genes |
-
2004
- 2004-10-22 NZ NZ591879A patent/NZ591879A/xx not_active IP Right Cessation
- 2004-10-22 US US10/972,135 patent/US20050191649A1/en not_active Abandoned
- 2004-10-22 NZ NZ603105A patent/NZ603105A/en not_active IP Right Cessation
- 2004-10-22 NZ NZ580169A patent/NZ580169A/en not_active IP Right Cessation
-
2006
- 2006-04-23 IL IL175089A patent/IL175089A/en not_active IP Right Cessation
-
2011
- 2011-02-03 JP JP2011021746A patent/JP2011142913A/ja not_active Withdrawn
-
2012
- 2012-05-15 JP JP2012111782A patent/JP2012183069A/ja active Pending
-
2013
- 2013-05-07 JP JP2013097618A patent/JP2013208117A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ603105A (en) | 2014-08-29 |
| JP2013208117A (ja) | 2013-10-10 |
| NZ591879A (en) | 2012-11-30 |
| JP2011142913A (ja) | 2011-07-28 |
| IL175089A0 (en) | 2006-08-20 |
| US20050191649A1 (en) | 2005-09-01 |
| NZ580169A (en) | 2011-04-29 |
| JP2012183069A (ja) | 2012-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9090947B2 (en) | Detection of mutations in a gene associated with resistance to viral infection, OAS1 | |
| JP2013208117A (ja) | ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出 | |
| US20070111231A1 (en) | Detection of mutations in a gene associated with resistance to viral infection, OAS2 and OAS3 | |
| AU2013228050B2 (en) | Detection of mutations in a gene associated with resistance to viral infection, oas1 | |
| Feucht et al. | The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b | |
| US20090186028A1 (en) | Detection of mutations in a gene associated with resistance to viral infection | |
| US20090155234A1 (en) | Detection of mutations in a gene associated with resistance to viral infection, mx1 | |
| TWI415944B (zh) | 偵測與病毒感染抗性有關基因(oasi)中之突變之方法 | |
| HK1151186A (en) | Oligoadenylate synthetase | |
| MXPA06004493A (en) | Detection of mutations in a gene associated with resistance to viral infection, oas1 | |
| HK1161740B (en) | Detection of mutations in a gene associated with resistance to viral infection, oas1 | |
| HK1193351A (en) | Detection of mutations in a gene associated with resistance to viral infection, oas1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |